Keyphrases
Somatostatin
100%
Neuroendocrine Neoplasms
100%
Ki-67 Index
75%
Cancer of Unknown Primary
50%
Pancreas
50%
Male-to-female Ratio
50%
Primary Tumor
50%
Prognostic Factors
50%
Tumor Grade
50%
Immunoreactivity
25%
Patient-reported Symptoms
25%
Poor Survival
25%
Treatment Survival
25%
Tumor Dissemination
25%
All-male
25%
Metastatic Disease
25%
Tumor Biology
25%
Biochemical Features
25%
Neuroendocrine Tumor
25%
Multiple Endocrine Neoplasia Type 1 (MEN1)
25%
Treatment Factors
25%
Neurofibromatosis Type 1 (NF-1)
25%
Survival Factor
25%
Duodenum
25%
Clinical Pathological Characteristics
25%
Neurofibromatosis Type I
25%
Working Diagnosis
25%
Disease Course
25%
Medicine and Dentistry
Somatostatin
100%
Neuroendocrine Tumor
100%
Diseases
75%
Neoplasm
50%
Primary Tumor
50%
Cancer of Unknown Primary Origin
50%
Metastatic Carcinoma
50%
Prognostic Factor
50%
Duodenum
25%
Tumor Biology
25%
Multiple Endocrine Neoplasia Type I
25%
Neurofibromatosis Type I
25%
Immunoreactivity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Somatostatinoma
50%
Multiple Endocrine Neoplasia Type 1
25%